Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
In Nashville, as anywhere in the United States, semaglutide requires a prescription from a clinician licensed in Tennessee, and the route can be a local clinic or a compliant telehealth evaluation. The more useful question is which semaglutide product you are actually asking about, because the two most-requested brands are not interchangeable: Ozempic is approved only for type 2 diabetes indications, while Wegovy carries the weight-management indications. Asking for the wrong one is the most common reason a request stalls.
Sort the Product Before You Sort the Appointment
The Ozempic label lists three indications, all in type 2 diabetes: glycemic control as an adjunct to diet and exercise, reduction of major adverse cardiovascular event risk in adults with type 2 diabetes and established cardiovascular disease, and reduction of the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
The Wegovy label covers cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight, long-term weight reduction in adults and in pediatric patients aged 12 and older with obesity and in adults with overweight plus at least one weight-related comorbid condition, and noncirrhotic MASH with moderate to advanced fibrosis under accelerated approval.
Semaglutide tablets exist as well. Rybelsus and Ozempic tablets share a label covering type 2 diabetes, and Wegovy tablets carry cardiovascular risk reduction and weight reduction indications in adults. Which document applies to you is determined by your diagnosis.
In-Person Options in Middle Tennessee
Nashville has a dense concentration of health systems, academic medical centres and independent practices, which makes primary care, endocrinology and obesity medicine all realistically available inside the metro. An in-person visit gives you a physical examination, direct measurement, and a same-day route to laboratory work.
The constraint is scheduling rather than availability, and it tightens quickly outside Davidson County. Specialist wait times for new patients in obesity medicine and endocrinology across Middle Tennessee are frequently measured in months, which is the practical reason many people look at telehealth in the first place.
What a Compliant Telehealth Route Looks Like
Telehealth changes where the evaluation happens, not whether it happens. The prescriber must hold a Tennessee licence and is accountable to the Tennessee Board of Medical Examiners. Semaglutide is not a controlled substance, so the federal restrictions specific to remote prescribing of controlled medications do not apply; state licensure and the standard of care are the governing constraints.
The FDA has published a list of telehealth red flags for this exact category. It flags companies that claim a compounded drug is the same as an FDA-approved drug, that offer deep discounts or prices that seem too good to be true, that do not require screening and a prescription by a licensed doctor before providing medicine, that have no licensed doctor available to answer questions after delivery, that make spelling errors or list incorrect pharmacy addresses on the label, or that ship medicine arriving warm or in damaged packaging.
That list is a practical screen. A platform failing any item on it is not offering a clinical service.
The Screening a Real Evaluation Includes
Whichever route you take, expect the same questions. Every semaglutide label carries a boxed warning about thyroid C-cell tumors observed in rodents and contraindicates use in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Beyond that, history of pancreatitis, gallbladder disease, severe gastrointestinal disease — the Ozempic label states it is not recommended in patients with severe gastroparesis — diabetic retinopathy, kidney impairment and pregnancy plans all change the assessment. The labeling directs discontinuation in women at least two months before a planned pregnancy because of the long washout period.
Your current medication list matters too, since delayed gastric emptying may affect absorption of oral drugs and the Wegovy label directs increased monitoring for those with a narrow therapeutic index.
Cost, Coverage and the Compounded Question
Coverage in Tennessee follows plan design rather than geography. Many plans carry a categorical exclusion for anti-obesity medications, which is a benefit-design decision that clinical documentation cannot overturn. Ask your plan in writing whether the category is excluded before building a prior authorization file.
Compounded semaglutide is a distinct category rather than a cheaper version of a brand. The FDA states that compounded drugs are not FDA approved and that the agency does not review them for safety, effectiveness or quality before marketing. There is no approved generic of any semaglutide product, so no compounded preparation is a generic of one.
A Short Checklist Before You Commit
Confirm the prescriber is licensed in Tennessee. Confirm which specific product is being prescribed and whether it is an FDA-approved brand or a compounded preparation. Confirm which pharmacy dispenses it and that the pharmacy is state-licensed.
Confirm how you reach a clinician after the first shipment, and confirm what the plan is if you do not tolerate the medication. The FDA’s own guidance is that patients should obtain a prescription from their doctor and fill it at a state-licensed pharmacy, and that a licensed doctor should be available to answer questions after you receive your medication.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Do I need to live in Nashville to be prescribed semaglutide by a Tennessee clinician?
The governing requirement is that the prescriber holds a licence in the state where you are located at the time of the encounter, not that either of you is in a particular city. Semaglutide is not a controlled substance, so the federal rules specific to remote prescribing of controlled medications do not apply. State licensure and the applicable standard of care are what govern.
Can I get Ozempic in Nashville for weight loss?
Ozempic has no weight-management indication anywhere in its labeling. Its three indications all concern type 2 diabetes: glycemic control, cardiovascular event risk reduction in adults with established cardiovascular disease, and reduction of the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with chronic kidney disease. Wegovy is the semaglutide product with weight-management indications.
How do I tell a legitimate telehealth platform from a bad one?
Use the FDA’s published red flags. Warning signs include claiming a compounded drug is the same as an FDA-approved drug, prices that seem too good to be true, no screening and prescription by a licensed doctor before medicine is provided, no licensed doctor available for questions afterward, spelling errors or incorrect pharmacy addresses on labels, and medicine arriving warm or in damaged packaging.
Is compounded semaglutide the same thing as Ozempic or Wegovy?
No. Compounded semaglutide is prepared by a licensed pharmacy against an individual prescription and is not an FDA-approved finished product; the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed. There are no approved generic versions of any semaglutide brand, so a compounded preparation cannot accurately be described as a generic of one.
What will a prescriber ask me about before writing a prescription?
Expect questions about personal or family history of medullary thyroid carcinoma and Multiple Endocrine Neoplasia syndrome type 2, since those are labeled contraindications, plus history of pancreatitis, gallbladder disease, severe gastrointestinal disease, diabetic retinopathy and kidney function. Pregnancy plans matter too, because labeling directs discontinuation at least two months before a planned pregnancy.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Combining Semaglutide and Testosterone: A Synergistic Approach to Health
What is GLP-1 Microdosing and How Can It Support Your Weight Loss Journey?